Fungi
In determining the susceptibility of fungi to chloramphenicol, a broth dilution method was employed. Serial dilutions of the drug in broth were dispensed in 1 ml. amounts in Wassermann tubes and to each tube was added 1 ml. of inoculum in broth. The tubes were incubated at 30°C. for one to seven days, depending upon the species, and then observed for inhibition of growth. The minimum concentration of the drug causing complete inhibition of growth was taken as the end point.
Modified Sabouraud's broth (dextrose 2 per cent, neo peptone 1 per cent) was used in preparing the dilutions of the drug and the fungus suspensions. In the case of the actinomycetes, Brain-Heart Infusion Broth (Difco) was employed.
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All of the fungi were tested first in a series of dilutions ranging from 50 to 1000 jg/ml. of the drug. The actinomycetes, Actinomyces bovis and Nocardia asteroides, were retested at lower concentrations and four species, Trichophyton interdigitale, T. mentagrophytes, T. rubrumn and Microsporum cans, at higher concentrations (up to 2500 .g/ml.) of chloramphenicol. In order to keep the drug in solution at the higher concentrations 1.8 ml. of the drug-broth mixture and 0.2 ml. of inoculum were used in each tube instead of 1 ml. of each as in the lower concentration series.
Spirochetes and Protozoa
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125,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 485,000 500,000 500,000 500,000 500,000 730,000 Tables I to IV. From Table I it appears that all of the Rickettsiae tested are susceptible to chloramphenicol. Coxiella burnetii (Q Fever) may be more resistant than the others as larger doses are required to produce corresponding delay in mean death time of treated embryos. Possibly the whole lymphogranuloma venereum-psittacosis group of virus (Miyagawanella) will prove to be as susceptible as the type species. There are indications that influenza virus in mice and the virus of Newcastle disease of chickens respond somewhat to comparatively massive doses of the drug. It is possible, however, that the therapeutic effect seen can be explained by the action of the drug upon secondary bacterial invaders. While this hypothesis is apparently borne out by the negative results with chloramphenicol on these viruses in embryonated eggs, further work and possibly controlled clinical trials are indicated.
Tests against the virus of poliomyelitis have proved negative. Dr in culture, which raises the speculation that possibly the apparent resistance of this group is a reflection of the resistance of the spores rather than of the vegetative forms.
While not within the scope of this paper, in vivo laboratory trials with certain of the bacterial agents have been conducted. Gould et al. (26) report encouraging results with the cholera vibrio in mice and Gruhzit (25) has found activity in mice ' Indicates number susceptible strains/number of strains tested.
against certain of the Gram-positive cocci and the salmonella group. Sarber (27) has treated mice infected with Hemophilus pertussis and found chloramphenicol to be an effective chemotherapeutic agent. Clinical trials are in progress against many of these pathogens. To date clinical confirmation has been obtained in typhoid fever (19) , brucellosis (20) , and certain urinary infections caused by Gram-negative species (21) .
Of the forty species or strains of fungi tested for susceptibility to chloramphenicol, Table III , only two were completely inhibited by the drug at the concentrations used in the test. These two species, Actinomyces bovis and Nocardia asteroides, both of which belong to the actinomycetes, were inhibited by 5 ug/ml. and 20 pfg/ml. of the drug, respectively. Since blood levels of this magnitude are easily attained, trial on clinical infections with these agents is indicated.
Growth of four species of ringworm fungi, Trichophyton mentagrophytes, T. interdigitale, T. rubrum and Microsporum canis, was retarded by 1000 ug/ml. of the drug but complete inhibition could not be obtained even when the drug concentration was increased to 2500 ,ug/ml.
With the possible exception of the spirochete of relapsing fever (Borrelia recurrentis), the results with the spirochetes and protozoa tested were not promising. Doses of 12.5 mg/Kg. twice daily for eight days were ineffective on syphilitic lesions in rabbits. Although similar treatment with 25 or 50 mg/Kg. cleared the lesions, relapses occurred when treatment was stopped.
Attempts to induce increased resistance to chloramphenicol by passage in the presence of the drug have been successful in the case of seven bacterial species, but not for R. prowazekii in the embryonated egg. It remains to be seen whether, under practical conditions in the clinic, this finding will be of importance.
